The mammalian target of rapamycin inhibitor everolimus suppresses proliferation, metabolic activity and collagen synthesis of human fibroblasts in vitro and exerts antifibrogenic effects in vivo
M. Böhm; A. Stegemann; D. Metze; K. Scharffetter‐Kochanek; A. Sindrilaru
Author Information: Department of Dermatology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.